INT Medical | Cardiac Catheters & Interventional Devices Manufacturer

admin 16 2026-05-12 02:26:22

Company Profile

Shanghai INT Medical Instruments Co., Ltd. is a China-based manufacturer of interventional cardiovascular and peripheral vascular devices, headquartered in Jiading District, Shanghai, China. Founded in June 2006 and listed on the Hong Kong Stock Exchange Main Board (HKEX: 01501) in 2019, the company operates as an independent publicly traded entity with KDL Holdings as its major shareholder, serving hospital catheterization labs and distributors across over 90 countries and regions. The group encompasses 24 subsidiaries spanning cardiology, peripheral vascular, neurovascular, electrophysiology, and structural heart.

Core Products & Technologies

Cardiac Interventional Devices

• Balloon Inflation Devices: High-pressure balloon pumps for PCI procedures with digital and analog gauge options
• Introducer Sheath Kits: Femoral and radial access sheaths with integrated hemostasis valves for catheter insertion
• Angiographic Guidewires: Hydrophilic and standard coating guidewires for coronary and peripheral vessel navigation
• Coronary Scoring Balloon Catheters: Nylon-cut scoring balloon for lesion preparation in calcified and fibrotic stenoses
• Guiding Catheters: Backup support catheters for complex coronary interventions

Peripheral & Neurovascular Systems

• Microcatheters & Microguidewires: Neurovascular and peripheral micro-systems for embolization and contrast injection
• Support Catheters: Distal access and aspiration catheters for thrombus removal and device delivery
• Balloon Guiding Catheters: Large-lumen catheters combining guide and balloon functionality for stroke interventions

Multi-Division Portfolio

• Electrophysiology: Diagnostic and ablation accessories for arrhythmia management
• Structural Heart: Transcatheter delivery accessories and occluder systems
• Urology & ENT: Interventional consumables for minimally invasive surgical specialties

Market Position & Certifications

INT Medical holds a leading domestic position in China's cardiac interventional accessory market, competing with MicroPort Scientific Corporation and Lepu Medical Technology. Key strengths include:

• 18+ years of interventional device engineering heritage with full vertical integration from mold design to ethylene oxide sterilization
• Regulatory compliance: ISO 13485, CE marked (43 product categories), and FDA registered (26 products)
• Intellectual property: 734 granted patents and 42 software copyrights as of 2025
• Enterprise honors: National Specialized and Innovative "Little Giant" SME, National IP Advantage Enterprise, Shanghai Enterprise Technology Center, Shanghai Innovative Enterprise Headquarters
• Sustainability recognition: Selected for S&P Global Sustainability Yearbook (China Edition) for two consecutive years (2024–2025)

Corporate Timeline

2006 — Founded in Shanghai as an interventional device manufacturer
2015 — Rebranded to Shanghai KDL Medical Devices Co., Ltd.
2019 — Listed on Hong Kong Stock Exchange Main Board (01501.HK)
2023 — Rebranded to Shanghai INT Medical Instruments Co., Ltd. (瑛泰医疗)
2024 — Coronary scoring balloon catheter approved by NMPA; selected for S&P Global Sustainability Yearbook
2025 — Acquired majority stake in Hangzhou Weiqiang Medical Technology; hydrophilic-coated guidewire approved; added 5 NMPA Class III and 14 Class II registrations; full-year revenue exceeded RMB 1 billion
2026 — January: Completed placement of shares to strengthen working capital and R&D capacity. April: Proposed abolition of supervisory board and revision of articles of association. May: Annual general meeting scheduled for May 28

Target Markets & Applications

• Coronary Interventions: PCI accessory devices for balloon angioplasty, stent delivery, and lesion preparation in cardiology departments
• Neurovascular Therapy: Microcatheters and guidewires for stroke intervention and aneurysm embolization
• Peripheral Vascular Disease: Access sheaths and guidewires for lower-extremity and renal artery procedures
• Structural Heart Procedures: Delivery system components for TAVR and left-atrial appendage closure
• Global OEM & Distribution: Private-label manufacturing and component supply for international medical device brands